Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Benton (NPI 1255667655)

Field	Value
Entity Type	Individual
Organization	Christopher Benton
Address	701 E Hampden Ave Ste 300
City	Englewood
State	CO
ZIP	80113
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	October 20, 2009

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

CHRISTOPHER BENTON is a hematology & oncology physician in Englewood, CO, with an NPI enumerated on 2009-10-20 (~17 years ago), indicating long-tenured Medicare participation and likely an established outpatient oncology practice. The code mix and descriptions (large volumes of antineoplastic and supportive-care injections plus E/M and infusion codes) point to a clinic that primarily delivers oncology therapeutics and associated infusion services rather than inpatient surgery or procedural subspecialty work.

Medicare drives the entirety of recorded public payer activity for this provider: Total Medicare revenue is $1.8M while there is no Medicaid billing on file, so this profile is effectively single-payer (Medicare) from the available claims data and any Medicaid-facing capacity is not evident in the dataset.

Revenue concentration is high: the precomputed top-3 Medicare codes account for 76.3% of the provider's Medicare revenue, indicating most dollars come from a very small set of drug administration codes rather than a broad mix of office visits or diagnostic testing. This concentration suggests the business is centered on dispensing specific high-cost therapies.

J0896 is the largest single revenue driver at $663.4K (39.6% of Medicare revenue) and J9271 contributes $533.2K (31.9%); together with the third top drug these codes form the majority of revenue. The prominence of J0896 (luspatercept) and J9271 (pembrolizumab) underscores a practice focused on specialty oncology/hematology biologic therapies and immunotherapy administration.

Competitive standing by code varies: the provider ranks #1 nationally for J0896 (100th percentile) despite the dataset noting only 2 providers nationally for that code, which indicates dominance for that specific drug in the available national sample. For J9271 the provider ranks #910 of 1841 (50th percentile), a middle-tier, typical national volume for pembrolizumab, while several E/M and infusion codes (e.g., 99214 rank in the 91st percentile, 99215 rank in the 97th percentile, 96413 rank in the 83rd percentile) show above-typical to notably-above-typical use relative to peers, signaling stronger-than-average office visit and chemotherapy administration volumes.

Service-line implications from the full CPT/HCPCS mix: high volumes of chemotherapy administration codes (96413, 96417, 96401), infusion management codes (G0498, 96365, 96367), and drug J-codes indicate the practice operates a clinic-based infusion suite providing systemic cancer therapy and supportive biologics. The presence of procedure codes such as 38222 (bone marrow biopsy) and flow cytometry add-on 88185 suggests diagnostic hematology capabilities are also offered or coordinated.

Payer and coding outliers are limited but notable: several routine venipuncture/lab codes (36415, 85025, 80053) are at very high national percentiles (96–99th), consistent with frequent on-site lab monitoring typical in oncology care. The profile includes codes labeled “notably above typical” (e.g., 99215 and 96372) and “typical, unremarkable” volumes for many specialty drug codes, indicating a mix of strong office-level utilization together with standard specialty drug dispensing patterns rather than across-the-board exceptional billing.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

78 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0896	Injection, luspatercept-aamt, 0.25 mg	21,400	$30	$663.4K
J9271	Injection, pembrolizumab, 1 mg	12,400	$40	$533.2K
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	2,460	$30	$81.2K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	35,090	$1	$70.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	530	$100	$50.5K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	360	$130	$48.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	380	$110	$39.4K
88185	The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with…	1,360	$20	$25.8K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	310	$80	$25.3K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	3,340	$10	$20K

Showing 1–10 of 78

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 78 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Christopher Benton — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

78 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0896	1	10	21,400	$30	$653.2K
J9271	13	40	10,700	$40	$520.5K
J1568	15	30	2,240	$30	$101.5K
Q5122	7	10	320	$90	$30.7K
J0881	1	10	7,670	$1	$23.4K
J3490	16	60	50	$290	$23.1K
Q5106	1	10	3,340	$10	$20.6K
96413	22	140	130	$100	$19.7K
J9217	51	60	100	$130	$15.6K
88185	2	10	520	$20	$14.7K

Showing 1–10 of 78

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christopher Benton, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nauman Moazzam	CO	Hematology & Oncology Physician	$3.6M	$0
Robert Rifkin	CO	Hematology & Oncology Physician	$3.3M	$0
Ioana Hinshaw	CO	Hematology & Oncology Physician	$2.7M	$0
John Burke	CO	Hematology & Oncology Physician	$2.6M	$0
Patrick Eulitt	CO	Medical Oncology Physician	$2.4M	$0
Patrick Richard	CO	Radiation Oncology Physician	$1.9M	$0
Paul Decarolis	CO	Hematology & Oncology Physician	$1.6M	$0
Maurice Markus	CO	Hematology & Oncology Physician	$1.6M	$0
Sujatha Nallapareddy	CO	Hematology & Oncology Physician	$1.4M	$0
Manojkumar Bupathi	CO	Hematology & Oncology Physician	$1.4M	$0

Nearby Providers

Other providers in the same ZIP code as Christopher Benton, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hca Healthone LLC	CO	General Acute Care Hospital	$0	$19.6M
Marion Health Associates, Inc.	CO	Assisted Living Facility	$0	$5.1M
Carepoint Emergency Medicine, PLLC	CO	Emergency Medicine Physician	$0	$4.1M
Novamed Surgery Center Of Denver LLC	CO	Ambulatory Surgical Clinic/Center	$2M	$248.7K
Evoke Medical Care LLC	CO	Cardiology Technician	$2M	$190.1K
Michael Smith	CO	Rheumatology Physician	$2M	$0
Eric Westerman	CO	Rheumatology Physician	$1.3M	$0
Robert Spencer	CO	Rheumatology Physician	$1.1M	$0
Cherie Reichart	CO	Rheumatology Physician	$1.1M	$0
Healthone Ridge View Endoscopy Center, LLC	CO	Ambulatory Surgical Clinic/Center	$695.4K	$114.4K

Christopher Benton — Billing Profile & Reimbursement Data

Sign up for Christopher Benton — Billing Profile & Reimbursement Data policy alerts

Christopher Benton — Billing Profile & Reimbursement Data

Sign up for Christopher Benton — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References